Electroconvulsive therapy in catatonia associated with pneumothorax.

Indian J Psychiatry

Ninan Thomas, MBBS, Medical Officer, Intensive Medical Care Unit, Vijaya Hospital, Madras - 600 026.

Published: April 1994

Recent advances in the method of application and monitoring of Electroconvulsive therapy (ECT) has facilitated its use even in the presence of serious physical illness. This case report b of a patient in catatonic stupor who developed an acute respiratory crisis, and in whom the use of ECT led to quick recovery not only from the psychiatric state but also helped recovery from the medical illness. The report highlights the need to use ECT, if indicated, in the presence of serious medical illness without hesitation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972467PMC

Publication Analysis

Top Keywords

electroconvulsive therapy
8
presence serious
8
medical illness
8
therapy catatonia
4
catatonia associated
4
associated pneumothorax
4
pneumothorax advances
4
advances method
4
method application
4
application monitoring
4

Similar Publications

Background: Electroconvulsive therapy (ECT) is an effective treatment for treatment-resistant depression (TRD). There are limited data on the improvement of anxiety symptoms in patients receiving ECT for TRD.

Objective: The aim of the study was to examine the extent to which anxiety symptom severity improves, relative to improvements in depressive symptoms, in TRD patients receiving an acute course of ECT.

View Article and Find Full Text PDF

There remains a scarcity of studies to evaluate the treatment effect of electroconvulsive therapy (ECT). Functional near-infrared spectroscopy (fNIRS) offers a cost-effective method to measure cerebral hemodynamics. This study used fNIRS to evaluate the effect of ECT in patients suffering from schizophrenia or bipolar disorder (manic phase).

View Article and Find Full Text PDF

Electroconvulsive therapy (ECT) is an effective treatment for severe depression, especially in treatment-resistant cases. However, its potential cognitive side effects necessitate careful dosing to balance therapeutic benefits and cognitive stability. Recent advances in electric field (E-field) modeling offer promising avenues to optimize ECT dosing.

View Article and Find Full Text PDF

Objectives: This study investigates repeated oral esketamine as a substitution strategy for maintenance electroconvulsive therapy (M-ECT) in eight patients with treatment-resistant depression (TRD).

Methods: In a 6-week dosing phase, esketamine was titrated from 0.5 or 1.

View Article and Find Full Text PDF

Outcomes of electroconvulsive therapy in adolescents with a depressive episode (depressive, bipolar disorders): a naturalistic retrospective cohort study.

Brain Stimul

January 2025

Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!